arrow
A

Alpesh Amin

division of hospital medicine and palliative medicine
H指数:44
被引数:9,874

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Fluid Management of Acute Heart Failure With the Reprieve System

使用Reprieve系统管理急性心力衰竭的液体

2026-05-010
PRE
Thrombotic microangiopathy multidisciplinary assessment team: demographics, final diagnosis, treatment, and outcomes

血栓性微血管病多学科评估团队:人口统计学特征、最终诊断、治疗及结局

2025-09-260
OAAI
Global Results of Implantable Loop Recorder for Detection of Atrial Fibrillation After Stroke: Reveal LINQ Registry
2024-10-250
OAAI
Management of Vulnerable Patients Hospitalized for COVID-19 With Remdesivir: A Retrospective Comparative Effectiveness Study of Mortality in US Hospitals

因Remdesivir新型冠状病毒肺炎住院的易受伤害患者的管理: 美国医院死亡率的回顾性比较有效性研究

2024-10-192
OAAI
Remdesivir Effectiveness in Reducing the Risk of 30-Day Readmission in Vulnerable Patients Hospitalized for COVID-19: A Retrospective US Cohort Study Using Propensity Scores

Remdesivir降低因新型冠状病毒肺炎住院的脆弱患者30天再入院风险的有效性: 一项使用倾向评分的回顾性美国队列研究

2024-10-150
OAAI
Lower Mortality Risk Associated With Remdesivir plus Dexamethasone Versus Dexamethasone Alone for the Treatment of Patients Hospitalized for COVID-19

与单独使用地塞米松相比,雷德西韦联合地塞米松治疗因新型冠状病毒肺炎住院的患者的死亡风险更低

2024-09-205
OAAI
Safety of SGLT2 inhibitors, DPP-4 inhibitors, and GLP-1 receptor agonists in US veterans with and without chronic kidney disease: a population-based study

SGLT2抑制剂,DPP-4抑制剂和GLP-1受体激动剂在患有和不患有慢性肾脏疾病的美国退伍军人中的安全性: 一项基于人群的研究

2024-08-013
OAAI